SEC Tracker
Get the app

TRex Bio TRXB

5,480,872 common shares owned

ELI LILLY & Co, new insider at TRex Bio, Inc.

Form
3
Filed
Importance
Routine
  1. 5,480,872 common shares owned
  2. 4,605,872 shares from convertible preferred stock
  3. 875,000 shares from IPO purchase
  4. Filing date: Oct 8, 2026

Written from the Form 3 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when TRex Bio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float not reported.

  1. Adaptimmune Therapeutics ADAP
  2. Adverum Biotechnologies ADVM
  3. AgomAb Therapeutics AGMB
  4. Alvotech ALVO
  5. Argenx ARGX

Data on this page was fetched . The filing on SEC.gov is the record.